AskTheDate.com
Back to calendar

Halozyme Therapeutics, Inc. (HALO) Earnings

HALO reports earnings on Thursday, August 6, 2026

earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $2.24
Actual EPS: $2.28
EPS surprise: 27.58%
Company overview
Market Cap$11.7B
PriceUSD 103.12
P/E30.81
EPS (TTM)3.35
52-week high103.30
52-week low61.23
SectorHealth Technology
IndustryBiotechnology
Employees423